Clinical Trials List
2005-12-01 - 2007-12-01
Phase III
Study ended10
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 李育霖 無
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Jen-Hsien Wang Division of Infectious Disease
- 何承懋 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 楊祖光 無
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Tun-Chieh Chen 無
- Chun-Yu Lin 無
- 林蔚如 無
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
750 participants
